This activity is supported by an unrestricted educational grant from Aerie Pharmaceuticals.
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education
Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve Medical Education, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Sponsored by:
Evolve is an approved COPE Administrator.
This activity, COPE Activity Number 122423, is accredited by COPE for continuing education for optometrists for 1.5 hours.
COPE Course ID: 74091-GL
COPE Activity ID: # 122423
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Douglas J. Rhee, MD
Chair, Department of Ophthalmology and Visual Sciences
Director, University Hospitals Eye Institute
Case Western Reserve University School of Medicine
Cleveland, OH
Nathan M. Radcliffe, MD
Glaucoma and Cataract Specialist
Associate Professor of Ophthalmology
Mount Sinai School of Medicine
Medical Director
New York Eye Surgery Center
New York, NY
Jody Piltz-Seymour, MD
Valley Eye Professionals, LLC
Wills Eye Hospital Glaucoma Service
Clinical Professor, Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA
Arsham Sheybani, MD
Associate Professor Professor of Ophthalmology and Visual Sciences
Washington University School of Medicine
St. Louis, MO
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Douglas J. Rhee, MD, has had a financial agreement or affiliation with the following ineligible companies in the form of Advisory Board: Ocular Therapeutix. Consultant: Aerie Pharmaceuticals, Allergan, and Ivantis. Grant/Research Support: Allergan, Glaukos, and Ivantis. Speaker’s Bureau: Aerie and Ivantis.
Nathan M. Radcliffe, MD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Alcon Laboratories, Alimera Sciences, Allergan, Bausch + Lomb, Beaver-Visitec International, Carl Zeiss Meditec, CATS, Ellex, ELT Sight, Equinox, Eyepoint, Glaukos Corporation, IRIDEX, Ivantis, Kala, Lumenis, New World Medical, Novartis Pharma AG, Ocular Science, Ocular Therapeutix, Omeros Corporation, Quantel Medical, Reichert, Santen, Shire, Sight Sciences, Spyglass, THEA, and ViaLase. Speaker’s Bureau: Aerie Pharmaceuticals, Alcon Laboratories, Alimera Sciences, Allergan, Bausch + Lomb, Beaver-Visitec International, Eyepoint, Glaukos Corporation, IRIDEX, Ivantis, Kala, Lumenis, New World Medical, Novartis Pharma AG, Reichert, and Sight Sciences. Stock/Shareholder: CATS, ELT Sight, Equinox, Ivantis, Sight Sciences, and Spyglass.
Jody Piltz-Seymour, MD, has had a financial agreement or affiliation during the past year with the following inelegible companies in the form of Consultant and Speaker's Bureau: Aerie Pharmaceuticals.
Arsham Sheybani, MD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: Alcon, Allergan, Ivantis, and Santen. Grant/Research Support: Allergan.
The Evolve staff, planners and peer reviewer have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Aerie Pharmaceuticals.
